Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use

Background: Monoclonal antibodies are a relatively new therapeutic option for patients with severe refractory asthma, which can be used as an add-on to maintenance therapy, reducing the need for systemic corticosteroid usage, improving asthma symptom control and reducing exacerbations. We report a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolasco, Santi, Campisi, Raffaele, Intravaia, Rossella, Porto, Morena, Pelaia, Corrado, Crimi, Nunzio, Crimi, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443779/
https://www.ncbi.nlm.nih.gov/pubmed/32864107
http://dx.doi.org/10.12688/f1000research.24603.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443779/
https://www.ncbi.nlm.nih.gov/pubmed/32864107
http://dx.doi.org/10.12688/f1000research.24603.2

Ejemplares similares